Pharma cos committed to 'science first' policy despite urgency: Industry body

Pharmaceutical companies are committed to a 'science first' approach in the development of COVID-19 vaccines even as the pressure piles on to end the pandemic, the representative of a Singapore-based industry body has said. Vaccine development is a complex process, traditionally it takes as long as 20 years, said Ashish Pal,...